These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 30642741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N, Futatsuya C, Mizutani KI, Kumagai M, Shioya A, Guo X, Aikawa A, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Yamada S.
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [Abstract] [Full Text] [Related]

  • 3. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y.
    Am J Hematol; 2021 Oct 01; 96(10):1241-1252. PubMed ID: 34265103
    [Abstract] [Full Text] [Related]

  • 4. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C, Igawa T, Gion Y, Iwaki N, Tabata T, Tanaka T, Kondo E, Sakai H, Tsuneyama K, Nomoto K, Noguchi H, Yoshino T, Yokota K, Sato Y.
    Pathol Int; 2019 Oct 01; 69(10):572-579. PubMed ID: 31631463
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E, Rubenstein A, Pierson SK, Dalldorf D, Frank D, Lim MS, Fajgenbaum DC.
    Hematol Oncol; 2022 Apr 01; 40(2):191-201. PubMed ID: 35104370
    [Abstract] [Full Text] [Related]

  • 10. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
    Takai K.
    Biomedicines; 2024 Mar 14; 12(3):. PubMed ID: 38540266
    [Abstract] [Full Text] [Related]

  • 11. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q, Zhang Y, Zhou G, Zhu J.
    BMC Nephrol; 2020 Nov 23; 21(1):499. PubMed ID: 33225930
    [Abstract] [Full Text] [Related]

  • 12. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, Aoki S, Kuroda J, Ide M, Setoguchi K, Tsukamoto N, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Masaki Y.
    Am J Hematol; 2019 Sep 23; 94(9):975-983. PubMed ID: 31222819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y, Ito K, Takamura A, Nagata K.
    J Med Case Rep; 2018 Oct 08; 12(1):295. PubMed ID: 30293532
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
    Maisonobe L, Bertinchamp R, Damian L, Gérard L, Berisha M, Guillet S, Fieschi C, Malphettes M, Fadlallah J, Hié M, Dunogué B, De Wilde V, Vandergheynst F, Zafrani L, Grall M, Saada N, Garzaro M, Oksenhendler E, Galicier L, Boutboul D.
    Br J Haematol; 2022 Feb 08; 196(3):599-605. PubMed ID: 34585382
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y, Hanayama Y, Fujii N, Kondo E, Otsuka F.
    Intern Med J; 2020 Feb 08; 50(2):184-191. PubMed ID: 31211492
    [Abstract] [Full Text] [Related]

  • 17. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
    Williams C, Phillips A, Aggarwal V, Slonim LB, Fajgenbaum DC, Karmali R.
    Case Rep Oncol; 2021 Feb 08; 14(3):1359-1365. PubMed ID: 34720942
    [Abstract] [Full Text] [Related]

  • 18. Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome.
    Sumiyoshi R, Koga T, Kawakami A.
    Biomedicines; 2024 May 21; 12(6):. PubMed ID: 38927348
    [Abstract] [Full Text] [Related]

  • 19. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH, Fan PY, Chen TD, Chuang WY, Wu CY, Ku CL, Tian YC, Yang CW, Fang JT, Yang HY.
    Int J Mol Sci; 2021 Jun 11; 22(12):. PubMed ID: 34208103
    [Abstract] [Full Text] [Related]

  • 20. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G, Marijanovic I, Srkalovic MB, Fajgenbaum DC.
    Bosn J Basic Med Sci; 2017 May 20; 17(2):81-84. PubMed ID: 28135567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.